Arrowstreet Capital Limited Partnership Acquires 1,438,702 Shares of The Cooper Companies, Inc. $COO

Arrowstreet Capital Limited Partnership lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 214.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,108,698 shares of the medical device company’s stock after buying an additional 1,438,702 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Cooper Companies were worth $172,829,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. New York Life Investment Management LLC increased its holdings in Cooper Companies by 0.6% in the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after acquiring an additional 158 shares in the last quarter. Root Financial Partners LLC boosted its holdings in Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares during the period. Allworth Financial LP boosted its holdings in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after buying an additional 167 shares during the period. Mesirow Financial Investment Management Inc. boosted its holdings in Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after buying an additional 175 shares during the period. Finally, Blue Trust Inc. boosted its holdings in Cooper Companies by 13.9% in the 4th quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after buying an additional 185 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. Citigroup reaffirmed a “neutral” rating and issued a $69.00 target price (down from $80.00) on shares of Cooper Companies in a report on Thursday, May 28th. Barclays lifted their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Wall Street Zen cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, Cooper Companies currently has a consensus rating of “Hold” and a consensus target price of $82.64.

Cooper Companies Stock Performance

Shares of COO opened at $67.88 on Monday. The company’s fifty day moving average is $64.79 and its 200 day moving average is $74.34. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The stock has a market capitalization of $13.24 billion, a PE ratio of 57.53, a P/E/G ratio of 1.78 and a beta of 0.88. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the previous year, the business posted $0.96 earnings per share. Cooper Companies’s quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.